Paloma Partners’s QuidelOrtho QDEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-6,300
Closed -$612K 1268
2022
Q2
$612K Buy
+6,300
New +$642K 0.02% 560
2022
Q1
Sell
-9,649
Closed -$1.3M 2135
2021
Q4
$1.3M Buy
+9,649
New +$1.34M 0.02% 588
2021
Q1
Sell
-20,006
Closed -$3.59M 2302
2020
Q4
$3.59M Sell
20,006
-4,383
-18% -$974K 0.09% 229
2020
Q3
$5.35M Sell
24,389
-64,774
-73% -$14.5M 0.14% 133
2020
Q2
$19.9M Buy
+89,163
New +$14M 0.35% 38
2019
Q1
Sell
-4,345
Closed -$212K 1885
2018
Q4
$212K Buy
+4,345
New +$259K 0.01% 1031
2018
Q2
Sell
-16,083
Closed -$834K 2094
2018
Q1
$834K Buy
+16,083
New +$749K 0.01% 1083
2015
Q4
Sell
-11,600
Closed -$219K 1884
2015
Q3
$219K Buy
+11,600
New +$248K 0.01% 1429

Other funds holding QDEL

Paloma Partners's QDEL Position: Q3 2022 in Review

Paloma Partners sold out of QuidelOrtho (QDEL) in Q3 2022, closing a stake of 6,300 shares — an estimated $612K sold.

Paloma Partners first reported a position in QDEL in Q3 2015 and held it in 8 quarters. The position peaked at $19.9M in Q2 2020. 315 funds tracked by Wall St. Rank hold QDEL as of Q3 2022.

  • Paloma Partners reported no remaining QuidelOrtho position as of Q3 2022 after selling out during the quarter.
  • Paloma Partners sold 6,300 QuidelOrtho shares in Q3 2022, an estimated $612K.
  • Paloma Partners first reported a position in QuidelOrtho in Q3 2015 and held it in 8 quarters.
  • Paloma Partners's QuidelOrtho position peaked at $19.9M in Q2 2020.
  • 315 funds tracked by Wall St. Rank held QuidelOrtho as of Q3 2022.

Based on Paloma Partners's 13F filing for Q3 2022, filed 14 Nov 2022.